A Phase 1 Study of TTI-621, a Novel Immune Checkpoint Inhibitor Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s | |
| Publication date | December 2, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://ashpublications.org/blood/article/128/22/1812/91499/A-Phase-1-Study-of-TTI621-a-Novel-Immune |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |